sherpa

Sherpa Healthcare Partners was founded in 2018, focusing on healthcare projects with rapid growth potential that are either based in China or closely related to local Chinese applications. These projects span various sectors, including but not limited to pharmaceuticals, medical devices, services, and internet and technological innovations related to healthcare. The core team of Sherpa has a long-standing history of collaboration, with members deeply rooted in the healthcare industry for many years. In particular, the three founding partners—Ouyang Xiangyu, Cai Daqing, and Xing Cheng—are seasoned veterans who have worked side by side on the front lines of healthcare investment. Their extensive experience and solid foundation of cooperation have made the team highly efficient and effective in project sourcing, investment decision-making, and post-investment management. Star projects such as Berry Genomics and WuXi AppTec have grown into industry leaders and successfully listed on the A-share market.